Essential tremor

The global deep brain stimulation devices market size is expected to reach USD 2.10 billion by 2025

Retrieved on: 
Tuesday, June 26, 2018

NEW YORK, June 26, 2018 /PRNewswire/ -- Deep Brain Stimulation Devices Market Size, Share & Trends Analysis Report By Application (Pain Management, Epilepsy, Essential Tremor, OCD, Depression, Dystonia, Parkinson's), By Region, And Segment Forecasts, 2018 - 2025

Key Points: 
  • NEW YORK, June 26, 2018 /PRNewswire/ -- Deep Brain Stimulation Devices Market Size, Share & Trends Analysis Report By Application (Pain Management, Epilepsy, Essential Tremor, OCD, Depression, Dystonia, Parkinson's), By Region, And Segment Forecasts, 2018 - 2025
    The global deep brain stimulation devices market size is expected to reach USD 2.10 billion by 2025 progressing at a CAGR of over 11.9% during the forecast period.
  • Growing prevalence of Parkinson's disease coupled with surging demand for cost-efficient surgical procedures, minimally invasive in nature, is providing a fillip to the market.
  • A significant rise in the usage of deep brain stimulators by neurologists in the treatment of various neurological diseases is supplementing the growth of the market.These diseases include Parkinson's disease, obsessive-compulsive disorder, essential tremors, and dystonia.
  • Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

INSIGHTEC's MR-Guided Focused Ultrasound Treatment for Essential Tremor Now Covered by Medicare

Retrieved on: 
Monday, June 4, 2018

INSIGHTEC , a global medical technology innovator of incisionless surgery, today announced that Medicare benefit coverage is available to patients in 10 U.S. states for MR-guided focused ultrasound (MRgFUS) for the treatment of essential tremor (ET).

Key Points: 
  • INSIGHTEC , a global medical technology innovator of incisionless surgery, today announced that Medicare benefit coverage is available to patients in 10 U.S. states for MR-guided focused ultrasound (MRgFUS) for the treatment of essential tremor (ET).
  • "By formalizing insurance coverage, Medicare is expanding access to focused ultrasound for many more patients and physicians."
  • Currently, MRgFUS for the treatment of essential tremor is covered by National Government Services (NGS) Medicare in 10 states: Connecticut, Maine, New Hampshire, Rhode Island, Vermont, New York, Massachusetts, Illinois, Wisconsin and Minnesota.
  • Additionally, CGS Medicare, Noridian Medicare and Palmetto GBA, local MACs for 22 other states, have posted positive draft LCDs specific for MRgFUS for the treatment of ET.

INSIGHTEC Submits Pre-market Approval to Japanese PMDA of MR-guided Focused Ultrasound Surgery for Treatment of Parkinson's Disease

Retrieved on: 
Monday, May 14, 2018

The Exablate Neuro, which uses focused ultrasound together with MR imaging to treat deep within the brain with no incisions, is intended to improve motor function and reduce dyskinesia.

Key Points: 
  • The Exablate Neuro, which uses focused ultrasound together with MR imaging to treat deep within the brain with no incisions, is intended to improve motor function and reduce dyskinesia.
  • Dyskinesia is one of the debilitating symptoms that presents as uncontrolled, involuntary movement of the arms and/or legs.
  • There are currently seven medical institutions in Japan performing the incisionless focused ultrasound treatment for essential tremor on a routine basis.
  • INSIGHTEC is a global medical technology innovator transforming patient lives through incisionless brain surgery with MR-guided focused ultrasound.

Evidence Shows Non-invasive Nerve Stimulation May Help with Hand Tremor

Retrieved on: 
Saturday, April 21, 2018

For the in-clinic study, participants received one session of either the treatment stimulation or sham stimulation to the wrist of the hand with the more severe tremor.

Key Points: 
  • For the in-clinic study, participants received one session of either the treatment stimulation or sham stimulation to the wrist of the hand with the more severe tremor.
  • Those who received treatment stimulation showed a 27 percent improvement compared to 16 percent for sham stimulation.
  • People receiving treatment stimulation showed a reduction in their tremor severity after 89.5 percent of the treatment stimulation sessions as measured by the sensors.
  • "Our research suggests that this non-invasive therapy may offer meaningful relief from the symptoms of hand tremor for people with essential tremor," Pahwa said.